[Studies on the transfer of cefotaxime into bone marrow blood]
- PMID: 3735666
[Studies on the transfer of cefotaxime into bone marrow blood]
Abstract
Cefotaxime (CTX) was administered in a dose of 2 g to 20 adult patients prior to orthopaedic surgery. Samples of the bone marrow blood and the forearm venous blood were collected at 30, 60, 90 and 120 minutes after the CTX administration, and the concentration of the drug in each sample was determined. The results are described below. The mean concentration of CTX transferred into the bone marrow blood was 59.7, 28.9, 14.7 and 7.2 micrograms/ml at 30, 60, 90 and 120 minutes after the CTX administration, respectively. The mean concentration of CTX in the venous blood was 84.0, 39.1, 19.0 and 13.8 micrograms/ml at 30, 60, 90 and 120 minutes after the CTX administration, respectively. The mean ratio of the CTX concentration in the bone marrow blood to that in the venous blood was 73.9%, 71.0%, 75.1% and 51.6% at 30, 60, 90, 120 minutes after the CTX administration. From the above results, CTX is considered to be a useful antibiotic if it is administered prior to orthopaedic surgery to prevent infections.
Similar articles
-
[Concentration of cefotaxime and its metabolite in human bone marrow blood].Jpn J Antibiot. 1986 Mar;39(3):739-45. Jpn J Antibiot. 1986. PMID: 3735667 Japanese.
-
[Penetration of cefotaxime into human bone marrow blood].Jpn J Antibiot. 1986 May;39(5):1273-8. Jpn J Antibiot. 1986. PMID: 3761555 Japanese.
-
[Study on cefotaxime in respiratory surgery: transfer to lung tissue and kinetics in serum].Jpn J Antibiot. 1989 Nov;42(11):2406-11. Jpn J Antibiot. 1989. PMID: 2621782 Japanese.
-
[Concentrations of cefotaxime in serum and myocardial tissue].Jpn J Antibiot. 1984 Jun;37(6):1035-9. Jpn J Antibiot. 1984. PMID: 6092737 Japanese.
-
Cefotaxime in the treatment of prophylaxis of surgical infections.J Chemother. 1997 May;9 Suppl 2:19-33. J Chemother. 1997. PMID: 9248973 Review.
Cited by
-
Cefotaxime. A reappraisal of its antibacterial activity and pharmacokinetic properties, and a review of its therapeutic efficacy when administered twice daily for the treatment of mild to moderate infections.Drugs. 1997 Mar;53(3):483-510. doi: 10.2165/00003495-199753030-00009. Drugs. 1997. PMID: 9074846 Review.
-
Cefotaxime. An update of its pharmacology and therapeutic use.Drugs. 1990 Oct;40(4):608-51. doi: 10.2165/00003495-199040040-00008. Drugs. 1990. PMID: 2083516 Review.